DNA Nanobots Funding Round

12/17/2025

Venture Equity

$3,500,000

Undisclosed

The company intends to use the funds to: Advance pre-clinical studies. Expand production capabilities. Expand IP portfolio. Strategic hires.

Private & Independent

Biopharmaceutical

1476 Manning Pkwy
Powell, OH 43065
USA

DNA Nanobots was founded in 2021 in Columbus, Ohio as an Ohio State University Spin-Out Company based on the work of Professor Carlos E. Castro. Since 2013, Professor Castro and colleagues have been diligently developing DNA based nanodevices (nanobots) for biomedical applications including targeted cancer drug delivery, vaccine platform development, and nucleic acid biosensing. With a broad intellectual property portfolio in place, DNA Nanobots is to be the world-wide leader and go-to company for product development services in the DNA nanomedicine space for the Biopharmaceutical, Biotechnology, and Academic industries. DNA Nanobots stands at the intersection of advanced biotech and pioneering nanotechnology, pushing the boundaries of what's possible in biology and medicine. Our commitment to innovation is reshaping the future of healthcare.